Retractions of scientific studies soar over past decade; Expanding Avila moves into bigger digs;

@FierceBiotech: Battery-powered patch delivers drugs for peripheral artery disease. More | Follow @FierceBiotech

@JohnCFierce: John Freund on FDA's tougher safety stance: "No venture capital firm will finance a new diabetes drug." Biotechs shunning big populations. | Follow @JohnCFierce

@MaureenFierce: NIH awards GMS Biotech an SBIR grant worth $115,762 to help it develop an array-based blood-screening device. Article | Follow @MaureenFierce

> New data from the Wall Street Journal indicates that while the number of papers being published has surged 44 percent over the past year, the number of retractions for mistakes has increased 15-fold. There were 22 retractions tracked in 2001, 399 last year. Report

> Avila Therapeutics has moved into bigger digs in Bedford, MA after outgrowing their office in Waltham. The company has taken a 23,000-square-foot facility as its new HQ. Item

The Boston Globe reports that a number of small and mid-sized biotech companies in the area-including Cubist and Ariad-have survived the recent market turmoil quite nicely. Story

> Forest Labs' management has won the backing of the proxy advisory firm ISS in its battle with Carl Icahn. More

Pharma News

@FiercePharma: Glass Lewis also says Icahn has identified 'several noteworthy issues' about Forest's performance. No problem with Mulligan's other board seats. | Follow @FiercePharma

> J&J, feds reach deal on one Risperdal charge. Report

> Proxy firm backs Icahn pick for Forest board. Article

Drug Delivery News

> Multitasking nanoparticles can do biosensing and drug delivery. News

> Professor edits special issue of Advanced Drug Delivery Reviews. Story

> Drug-Delivery company Osmotica to announce expansion near Atlanta. Article

> Self-assembling microrobot for drug delivery? Sure, why not? Details

> Bucky balls can do it all, delivering imaging agents and therapy. More

> Battery-powered patch delivers drugs for peripheral artery disease. Report

Medical Device News

> Stereotaxis sees revenues down, CFO to leave. Story

> Verinata closes $48.5M Series C. News

> TrovaGene regains rights to tech for prenatal testing, cancer. Report

> Magellan launches website, apps to track radiation exposure from imaging. More

And Finally... Tufts University researchers have determined that blood tests used to identify the gender of a fetus is 95% accurate at seven weeks. The tests have raised questions whether couples have been using the technology to determine whether they will continue the pregnancy or end it. Story